CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −286 | $171.92 | $49K | 97,931 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,820 | $173.45 | $316K | 96,111 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −655 | $174.28 | $114K | 95,456 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −702 | $175.73 | $123K | 94,754 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −4,358 | 8,715 | ||
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −7,945 | 31,780 | ||
| 2026-01-02 | Smith Michael Alexander Chief Legal Officer | Grant or award | +5,293 | 60,195 | ||
| 2026-01-02 | Smith Michael Alexander Chief Legal Officer | Grant or award · Stock Option (right to buy) | +27,600 | 27,600 | ||
| 2026-01-02 | Flammer Martina M.D. Chief Medical Officer | Grant or award 10b5-1 | +5,998 | 89,109 | ||
| 2026-01-02 | Flammer Martina M.D. Chief Medical Officer | Grant or award 10b5-1 | +5,645 | 94,754 | ||
| 2026-01-02 | Flammer Martina M.D. Chief Medical Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +31,280 | 31,280 | ||
| 2026-01-02 | Adsett Roger Chief Operating Officer | Grant or award | +5,998 | 111,891 | ||
| 2026-01-02 | Adsett Roger Chief Operating Officer | Grant or award · Stock Option (right to buy) | +31,280 | 31,280 | ||
| 2026-01-02 | Bonstein Sara Chief Financial Officer | Grant or award | +5,998 | 79,503 | ||
| 2026-01-02 | Bonstein Sara Chief Financial Officer | Grant or award | +5,645 | 85,148 | ||
| 2026-01-02 | Bonstein Sara Chief Financial Officer | Grant or award · Stock Option (right to buy) | +31,280 | 31,280 | ||
| 2026-01-02 | Lewis William Chair and CEO | Grant or award | +21,172 | 325,083 | ||
| 2026-01-02 | Lewis William Chair and CEO | Grant or award · Stock Option (right to buy) | +110,400 | 110,400 | ||
| 2026-01-02 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award 10b5-1 | +5,293 | 41,754 | ||
| 2026-01-02 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Option exercise 10b5-1 | +87,290 | $13.91 | $1.2M | 129,044 |
Page 12 of 23 · 448 trades